These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 28267152)

  • 1. Effects of naltrexone are influenced by childhood adversity during negative emotional processing in addiction recovery.
    Savulich G; Riccelli R; Passamonti L; Correia M; Deakin JF; Elliott R; Flechais RS; Lingford-Hughes AR; McGonigle J; Murphy A; Nutt DJ; Orban C; Paterson LM; Reed LJ; Smith DG; Suckling J; Tait R; Taylor EM; Sahakian BJ; Robbins TW; Ersche KD
    Transl Psychiatry; 2017 Mar; 7(3):e1054. PubMed ID: 28267152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granger causality reveals a dominant role of memory circuit in chronic opioid dependence.
    Zhang Y; Li Q; Wen X; Cai W; Li G; Tian J; Zhang YE; Liu J; Yuan K; Zhao J; Wang W; Zhou Z; Ding M; Gold MS; Liu Y; Wang GJ
    Addict Biol; 2017 Jul; 22(4):1068-1080. PubMed ID: 26987308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone ameliorates functional network abnormalities in alcohol-dependent individuals.
    Morris LS; Baek K; Tait R; Elliott R; Ersche KD; Flechais R; McGonigle J; Murphy A; Nestor LJ; Orban C; Passetti F; Paterson LM; Rabiner I; Reed L; Smith D; Suckling J; Taylor EM; Bullmore ET; Lingford-Hughes AR; Deakin B; Nutt DJ; Sahakian BJ; Robbins TW; Voon V;
    Addict Biol; 2018 Jan; 23(1):425-436. PubMed ID: 28247526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroimaging findings from an experimental pharmacology trial of naltrexone in heavy drinkers of East Asian descent.
    Lim AC; Ghahremani DG; Grodin EN; Green R; Bujarski S; Hartwell EE; Courtney KE; Hutchison K; Miotto K; Ray LA
    Drug Alcohol Depend; 2019 Jul; 200():181-190. PubMed ID: 31160146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdiagnostic Effects of Ventromedial Prefrontal Cortex Transcranial Magnetic Stimulation on Cue Reactivity.
    Kearney-Ramos TE; Dowdle LT; Lench DH; Mithoefer OJ; Devries WH; George MS; Anton RF; Hanlon CA
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Jul; 3(7):599-609. PubMed ID: 29776789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of extended-release naltrexone on the brain response to drug-related stimuli in patients with opioid use disorder.
    Shi Z; Wang AL; Jagannathan K; Fairchild VP; O'Brien CP; Childress AR; Langleben DD
    J Psychiatry Neurosci; 2018 Jul; 43(4):254-261. PubMed ID: 29947607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naltrexone differentially modulates the neural correlates of motor impulse control in abstinent alcohol-dependent and polysubstance-dependent individuals.
    Nestor LJ; Paterson LM; Murphy A; McGonigle J; Orban C; Reed L; Taylor E; Flechais R; Smith D; Bullmore ET; Ersche KD; Suckling J; Elliott R; Deakin B; Rabiner I; Lingford Hughes A; Sahakian BJ; Robbins TW; Nutt DJ;
    Eur J Neurosci; 2019 Aug; 50(3):2311-2321. PubMed ID: 30402987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-release naltrexone modulates brain response to drug cues in abstinent heroin-dependent patients.
    Langleben DD; Ruparel K; Elman I; Loughead JW; Busch EL; Cornish J; Lynch KG; Nuwayser ES; Childress AR; O'Brien CP
    Addict Biol; 2014 Mar; 19(2):262-71. PubMed ID: 22747521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linking genes, circuits, and behavior: network connectivity as a novel endophenotype of externalizing.
    Sadeh N; Spielberg JM; Logue MW; Hayes JP; Wolf EJ; McGlinchey RE; Milberg WP; Schichman SA; Stone A; Miller MW
    Psychol Med; 2019 Aug; 49(11):1905-1913. PubMed ID: 30207258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cue reactivity and opioid blockade in amphetamine dependence: A randomized, controlled fMRI study.
    Guterstam J; Jayaram-Lindström N; Berrebi J; Petrovic P; Ingvar M; Fransson P; Franck J
    Drug Alcohol Depend; 2018 Oct; 191():91-97. PubMed ID: 30096639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medial prefrontal neuroplasticity during extended-release naltrexone treatment of opioid use disorder - a longitudinal structural magnetic resonance imaging study.
    Shi Z; Li X; Todaro DR; Cao W; Lynch KG; Detre JA; Loughead J; Langleben DD; Wiers CE
    Transl Psychiatry; 2024 Sep; 14(1):360. PubMed ID: 39237534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do alcohol-dependent patients show different neural activation during response inhibition than healthy controls in an alcohol-related fMRI go/no-go-task?
    Czapla M; Baeuchl C; Simon JJ; Richter B; Kluge M; Friederich HC; Mann K; Herpertz SC; Loeber S
    Psychopharmacology (Berl); 2017 Mar; 234(6):1001-1015. PubMed ID: 28161772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone Acutely Enhances Connectivity Between the Ventromedial Prefrontal Cortex and a Left Frontoparietal Network.
    Elton A; Dove S; Spencer CN; Robinson DL; Boettiger CA
    Alcohol Clin Exp Res; 2019 May; 43(5):965-978. PubMed ID: 30848494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of Pharmacological Opioid Blockade on Neural Measures of Drug Cue-Reactivity in Humans.
    Courtney KE; Ghahremani DG; Ray LA
    Neuropsychopharmacology; 2016 Nov; 41(12):2872-2881. PubMed ID: 27312405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute naltrexone does not remediate fronto-striatal disturbances in alcoholic and alcoholic polysubstance-dependent populations during a monetary incentive delay task.
    Nestor LJ; Murphy A; McGonigle J; Orban C; Reed L; Taylor E; Flechais R; Paterson LM; Smith D; Bullmore ET; Ersche KD; Suckling J; Tait R; Elliott R; Deakin B; Rabiner I; Lingford-Hughes A; Nutt DJ; Sahakian B; Robbins TW;
    Addict Biol; 2017 Nov; 22(6):1576-1589. PubMed ID: 27600363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased corticolimbic connectivity in cocaine dependence versus pathological gambling is associated with drug severity and emotion-related impulsivity.
    Contreras-Rodríguez O; Albein-Urios N; Vilar-López R; Perales JC; Martínez-Gonzalez JM; Fernández-Serrano MJ; Lozano-Rojas O; Clark L; Verdejo-García A
    Addict Biol; 2016 May; 21(3):709-18. PubMed ID: 25818325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype.
    Ziauddeen H; Nestor LJ; Subramaniam N; Dodds C; Nathan PJ; Miller SR; Sarai BK; Maltby K; Fernando D; Warren L; Hosking LK; Waterworth D; Korzeniowska A; Win B; Richards DB; Vasist Johnson L; Fletcher PC; Bullmore ET
    Neuropsychopharmacology; 2016 Oct; 41(11):2647-57. PubMed ID: 27109624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of nalmefene on emotion processing in alcohol use disorder - A randomized, controlled fMRI study.
    Vollstädt-Klein S; Bumb JM; Otto A; Dinter C; Karl D; Koopmann A; Hermann D; Mann K; Kiefer F
    Eur Neuropsychopharmacol; 2019 Dec; 29(12):1442-1452. PubMed ID: 31740271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preliminary randomized clinical trial of naltrexone reduces striatal resting state functional connectivity in people with methamphetamine use disorder.
    Kohno M; Dennis LE; McCready H; Schwartz DL; Hoffman WF; Korthuis PT
    Drug Alcohol Depend; 2018 Nov; 192():186-192. PubMed ID: 30266003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased subcortical volumes in alcohol dependent individuals: effect of polysubstance use disorder.
    Grodin EN; Momenan R
    Addict Biol; 2017 Sep; 22(5):1426-1437. PubMed ID: 27334243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.